As more children survive cancer, pediatric oncologists are shifting their focus from cure rates alone to the long-term side ...

AI is changing breast cancer screening, helping doctors detect cancer and predict future risk. Learn what AI mammography ...

Sustained therapeutic rapport and reassurance can reduce patient anxiety and improve perceived readiness to endure prolonged, ...

Two and a half years into cancer treatment, my nurse Jenny Gnoza still greets me with a smile, steadies my nerves and finds the vein everyone else misses.

Dr. Doured Daghistani explains how pediatric oncology is shifting toward reducing long-term side effects as childhood cancer survival rates rise.

Accelerated approval targets acquired endocrine resistance, specifically ESR1-mutant disease emerging on aromatase inhibitor ...

Personalized cancer treatment aims to match patients with therapies based on specific features of their cancer, but tumors ...

Cancer can change, hide from the immune system and escape treatment, making effective therapy about more than targeting cancer cells alone.

Former NFL linebacker Chris Draft honors his late wife Keasha by advocating for lung cancer research and equitable access to ...

Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...

T-cell redirecting platforms function by enabling antigen-specific recognition or by colocalizing effector T cells with tumor ...

The FDA approved six cancer drugs in August 2026, including a landmark pancreatic cancer pill. Here's what each approval ...